These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 6233003
21. Activity of oxaliplatin against human tumor colony-forming units. Raymond E, Lawrence R, Izbicka E, Faivre S, Von Hoff DD. Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898 [Abstract] [Full Text] [Related]
22. Comparative cytotoxicity of adriamycin, mitoxantrone and bisantrene as measured by a human tumor cloning system. Cowan JD, Von Hoff DD, Clark GM. Invest New Drugs; 1983 Apr; 1(2):139-44. PubMed ID: 6678863 [Abstract] [Full Text] [Related]
23. [Clinical correlations of drug sensitivity in the human tumor clonogenic assay--heterogeneity in drug sensitivity of human tumors]. Tanigawa N, Hikasa Y, Kern DH. Gan No Rinsho; 1984 Jul; 30(9 Suppl):1152-7. PubMed ID: 6471422 [Abstract] [Full Text] [Related]
26. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines. Chang BK. Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624 [Abstract] [Full Text] [Related]
32. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts. Taetle R, Koessler AK, Howel SB. Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353 [Abstract] [Full Text] [Related]
33. Preclinical discovery of ixabepilone, a highly active antineoplastic agent. Lee FY, Borzilleri R, Fairchild CR, Kamath A, Smykla R, Kramer R, Vite G. Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795 [Abstract] [Full Text] [Related]
34. Phase II study of ametantrone in a human tumor cloning assay. Rozencweig M, Sanders C, Rombaut W, Crespeigne N, Kenis Y, Klastersky J. Eur J Cancer Clin Oncol; 1985 Feb; 21(2):195-8. PubMed ID: 3987756 [Abstract] [Full Text] [Related]
35. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay]. Kurbacher CM, Brenne U, Kurbacher JA, Mallmann P, Krebs D. Zentralbl Gynakol; 1996 Feb; 118(5):271-8. PubMed ID: 8701623 [Abstract] [Full Text] [Related]
36. Growth and ultrastructural responses of T-47D human breast tumor cells to treatment with mitoxantrone. Safa AR, Ballou RJ, Tseng MT. Cancer Detect Prev; 1985 Feb; 8(4):455-64. PubMed ID: 4053107 [Abstract] [Full Text] [Related]
37. Trimetrexate: a second generation folate antagonist in clinical trial. Lin JT, Bertino JR. J Clin Oncol; 1987 Dec; 5(12):2032-40. PubMed ID: 2960788 [Abstract] [Full Text] [Related]
38. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells. Bowen D, Southerland WM, Johnson DH, Hawkins M, Hughes DE. Cancer Detect Prev; 2000 Dec; 24(5):452-8. PubMed ID: 11129987 [Abstract] [Full Text] [Related]